|
Search
Collections
Benchmarks
Upload document
LP-184
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 product
1 abstract
1 target
Target
ERCC3
Abstract
Tumor sensitization to PARP inhibitors by DNA damaging synthetically lethal acylfulvenes.
Org:
Lantern Pharma,
Product
LP-184
